These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33592065)

  • 21. Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.
    Pastrana DV; Brennan DC; Cuburu N; Storch GA; Viscidi RP; Randhawa PS; Buck CB
    PLoS Pathog; 2012; 8(4):e1002650. PubMed ID: 22511874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shedding Light on Viral Shedding: Novel Insights into Nuclear Assembly, Cytoplasmic Transformation and Extracellular Vesicle Release of the BK Virus.
    Gerges D; Abd El-Ghany K; Hevesi Z; Aiad M; Omic H; Baumgartner C; Winnicki W; Eder M; Schmidt A; Eskandary F; Wagner L
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection.
    Hainley LE; Hughson MS; Narendran A; Smith R; Arthur J; Hayner-Buchan A; Conti DJ; Lehman JM; Friedrich TD
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of COS-BK cells persistently infected with archetype BK polyomavirus.
    Nukuzuma S; Onogi H; Suzuki T
    Microbiol Immunol; 2024 May; 68(5):179-184. PubMed ID: 38433377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
    Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
    Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling BK Polyomavirus dissemination and cytopathology using polarized human renal tubule epithelial cells.
    Lorentzen EM; Henriksen S; Rinaldo CH
    PLoS Pathog; 2023 Aug; 19(8):e1011622. PubMed ID: 37639485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.
    Peretti A; Geoghegan EM; Pastrana DV; Smola S; Feld P; Sauter M; Lohse S; Ramesh M; Lim ES; Wang D; Borgogna C; FitzGerald PC; Bliskovsky V; Starrett GJ; Law EK; Harris RS; Killian JK; Zhu J; Pineda M; Meltzer PS; Boldorini R; Gariglio M; Buck CB
    Cell Host Microbe; 2018 May; 23(5):628-635.e7. PubMed ID: 29746834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.
    Wunderink HF; de Brouwer CS; van der Meijden E; Pastrana DV; Kroes ACM; Buck CB; Feltkamp MCW
    J Clin Virol; 2019 Jan; 110():22-28. PubMed ID: 30529638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human fetal glial cell line SVG p12 contains infectious BK polyomavirus.
    Henriksen S; Tylden GD; Dumoulin A; Sharma BN; Hirsch HH; Rinaldo CH
    J Virol; 2014 Jul; 88(13):7556-68. PubMed ID: 24760884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.
    van Aalderen MC; Remmerswaal EB; Heutinck KM; Ten Brinke A; Feltkamp MC; van der Weerd NC; van der Pant KA; Bemelman FJ; van Lier RA; Ten Berge IJ
    PLoS Pathog; 2016 Oct; 12(10):e1005903. PubMed ID: 27723787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.
    Helle F; Aubry A; Morel V; Descamps V; Demey B; Brochot E
    J Am Soc Nephrol; 2024 Oct; 35(10):1425-1433. PubMed ID: 39352862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction Between Human Polyomavirus BK and Hypoxia Inducible Factor-1 alpha.
    Signorini L; Croci M; Boldorini R; Varella RB; Elia F; Carluccio S; Villani S; Bella R; Ferrante P; Delbue S
    J Cell Physiol; 2016 Jun; 231(6):1343-9. PubMed ID: 26529465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BK polyomavirus in kidney transplant recipients: screening, monitoring and clinical management.
    Varella RB; Almeida JR; Lopes Pde F; Matos JP; Menezes P; Lugon JR
    J Bras Nefrol; 2014; 36(4):529-34. PubMed ID: 25517283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
    Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
    Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent cytomegalovirus glomerulitis and BK polyomavirus-associated nephropathy in a kidney allograft biopsy.
    Chikeka IO; Paulk A; Haririan A; Papadimitriou JC; Drachenberg CB
    Transpl Infect Dis; 2016 Apr; 18(2):247-50. PubMed ID: 26782090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.